Espicom Healthcare Intelligence Research Reports

Title	Published	Price
The Outlook for Pharmaceuticals in North East Asia to 2013 By: Espicom Healthcare Intelligence Detailed analysis of four pharma markets which present immense potential for pharmaceutical manufacturers Japan, China, South Korea and Taiwan are ranked among the biggest pharmaceutical markets in the world. In 2008, the countries covered in \| more...	periodical	$3,790.00
Boehringer Ingelheim Pharmaceutical Company Intelligence Report By: Espicom Healthcare Intelligence Boehringer Ingelheim is headquartered in Ingelheim am Rhein, Germany, where it has been located since its foundation in 1885. It has operating activities in more than 60 countries throughout the world and is involved \| more... Search inside this report	1/25/2005	$595.00
Neurodegenerative Drug Futures By: Espicom Healthcare Intelligence Espicom Business Intelligence, publisher of the respected business newsletter CNS Drug News, has produced this thought-provoking analysis Neurodegenerative Drug Futures. Neurodegenerative disorders are estimated to affect over 22 million people worldwide. Whilst many palliative \| more... Search inside this report	2/7/2005	$1,995.00
Cooper Companies Medical Device Company Intelligence Report By: Espicom Healthcare Intelligence Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included \| more... Search inside this report	3/1/2005	$560.00
Sumitomo Pharmaceutical Company Intelligence Report By: Espicom Healthcare Intelligence Pharmaceutical Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on \| more... Search inside this report	3/2/2005	$595.00
Aphton Cancer Company Intelligence Report By: Espicom Healthcare Intelligence Incorporated in 1981, Aphton is a biopharmaceutical company focused on the development and commercialisation of pharmaceutical products for the treatment of cancer and gastrointestinal (GI) disease. Its research and development efforts are based on its \| more...	3/16/2005	$195.00
Arqule Cancer Company Intelligence Report By: Espicom Healthcare Intelligence ArQule was incorporated in 1993, and completed a public offering in 1996. ArQule is a biotechnology company engaged in the research and development of cancer therapeutics. Its mission is to research, develop and commercialise broadly \| more...	3/16/2005	$195.00
Biomira Cancer Company Intelligence Report By: Espicom Healthcare Intelligence Incorporated on 23rd August 1985, Biomira is an international biotechnology company which is engaged primarily in the research and development of products to treat cancer. The company's R&D efforts are currently focused on its core \| more...	3/16/2005	$195.00
Bristol-Myers Squibb Cancer Company Intelligence Report By: Espicom Healthcare Intelligence Founded in 1989, Bristol-Myers Squibb is a diversified global health and personal care company. BMS’ Oncology Therapeutics Network (OTN) segment is a leading specialty distributor of oncology drugs, supportive care products and related \| more...	3/16/2005	$195.00
Cell Genesys Cancer Company Intelligence Report By: Espicom Healthcare Intelligence Incorporated in April 1988, Cell Genesys is focused on the development and commercialisation of novel biological therapies for patients with cancer. The company has multiple clinical stage product development programmes, a deep product pipeline in \| more...	3/16/2005	$195.00
Cel-Sci Cancer Company Intelligence Report By: Espicom Healthcare Intelligence Formed in March 1983, CEL-SCI is developing new immune system-based treatments for cancer and infectious diseases. The company's primary focus is the development of its immunotherapy product, Multikine. CEL-SCI's patented T-cell Modulation Process uses \| more...	3/16/2005	$195.00
Coley Pharmaceutical Cancer Company Intelligence Report By: Espicom Healthcare Intelligence Coley Pharmaceutical Group is a private company that was founded in 1997 to discover, develop and commercialise drugs based on CpG oligonucleotides (oligos). Since then, Coley scientists and their colleagues have continued to identify novel \| more...	3/16/2005	$195.00
Kirin Brewery Cancer Company Intelligence Report By: Espicom Healthcare Intelligence Incorporated on 23rd February 1907, the Kirin Group comprises a diversified number of companies concentrating on various sectors. The structure of the Kirin Group was reorganised in 2001 into a holding company, business companies and \| more...	3/16/2005	$195.00
Peregrine Pharmaceuticals Cancer Company Intelligence Report By: Espicom Healthcare Intelligence Founded in April 1999, Panacea Pharmaceuticals is a privately-held, emerging biopharmaceutical company focused on utilising functional genomics and proteomics to develop therapeutic agents and diagnostic tests for diseases of cancer and the central nervous system. \| more...	3/16/2005	$195.00
Protherics Cancer Company Intelligence Report By: Espicom Healthcare Intelligence Protherics was formed in September 1999 from the merger of Proteus International Plc and Therapeutic Antibodies Inc. Protherics is a biopharmaceutical business focused on immunotherapeutic research and development. The company has R&D laboratories in Runcorn, \| more...	3/16/2005	$195.00
Intarcia Therapeutics Cancer Company Intelligence Report (FORMERLY BIOMEDICINES) By: Espicom Healthcare Intelligence Intarcia Therapeutics was founded by Dr Mark Moran in 1997 and specialises in developing and systematically generating new uses for clinical-stage drugs purchased or licensed from major pharmaceutical companies. The company was originally called BioMedicines, \| more...	3/16/2005	$195.00
Synta Pharmaceuticals Cancer Company Intelligence Report By: Espicom Healthcare Intelligence Synta, which commenced operations in July 2001, is a product-focused biopharmaceutical company developing novel, small-molecule drugs for cancer, inflammatory diseases and diabetes. All of its products were developed internally using the company’s chemistry-driven drug-discovery platform. \| more...	3/16/2005	$195.00
Access Pharmaceuticals Cancer Company Intelligence Report By: Espicom Healthcare Intelligence Access Pharmaceuticals was incorporated in 1974 as Chemex Corporation, and in 1983, changed its name to Chemex Pharmaceuticals Inc. In January 1996, Chemex merged with Access Pharmaceuticals Inc to create the existing company. \| more...	3/16/2005	$195.00
Anosys Cancer Company Intelligence Report By: Espicom Healthcare Intelligence Anosys is a privately-held biotechnology company which develops and tests medicines to treat cancer, infectious and autoimmune diseases. The company's approach to immunotherapy is based on the discovery of a fundamental mechanism of immunity that \| more...	3/16/2005	$195.00
ONCOGENEX TECHNOLOGIES Cancer Company Intelligence Report By: Espicom Healthcare Intelligence Incorporated in May 2000, OncoGenex is a clinical-stage biotechnology company dedicated to improving survival and quality of life of cancer patients by developing targeted therapeutics for treatment-resistant and metastatic cancer. OncoGenex’ ability to \| more...	3/18/2005	$195.00
The Indian Medical Device Market: Challenges & Opportunities By: Espicom Healthcare Intelligence The Indian Medical Device Market: Challenges & Opportunities is essential to really understanding the business potential for manufacturers, investors and the service industry. In more than 150 pages, the report provides an information rich and \| more... Search inside this report	3/31/2005	$995.00
Roche Pharmaceutical Company Intelligence Report By: Espicom Healthcare Intelligence Pharmaceutical Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included on \| more... Search inside this report	3/31/2005	$595.00
The Indian Pharmaceutical Market: Challenges & Opportunities By: Espicom Healthcare Intelligence The Indian Pharmaceutical Market: Challenges & Opportunities is essential to really understanding the business potential for manufacturers, investors and the service industry. In more than 150-pages, the report provides an information rich and readable analysis, \| more... Search inside this report	4/7/2005	$1,215.00
Belarus Outlook Medical Market Intelligence Report By: Espicom Healthcare Intelligence Medistat Outlook Reports are ideal for executives wanting to understand the key drivers in medical markets worldwide. Each report provides a comprehensive analysis of the market and, importantly, provides 5-year forecasts by technology category, \| more... Search inside this report	4/21/2005	$595.00
Arrow Medical Device Company Intelligence Report By: Espicom Healthcare Intelligence Medical Device Company Intelligence Reports provide a full review of the company's activities, from its origins to its latest corporate activity, including mergers and acquisitions, agreements, divestitures, major purchasing contracts and litigation. Sections are included \| more... Search inside this report	5/25/2005	$595.00
Title	Published	Price

< prev 1 2 3 4 5 6 7 8 9 10 next >

Phone: 800.298.5699 (US) or +1.240.747.3093 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: customerservice@marketresearch.com
Copyright © 1999-2009, All Rights Reserved, MarketResearch.com
11/23/2009 - 3